多発性神経炎(多発性ニューロパチー)治療のグローバル臨床試験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Polyneuropathies Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Polyneuropathies 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Polyneuropathies to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Polyneuropathies to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Polyneuropathies 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Polyneuropathies Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Pfizer Inc. 32
Clinical Trial Overview of Pfizer Inc. 32
NeurogesX, Inc. 33
Clinical Trial Overview of NeurogesX, Inc. 33
CSL Limited 34
Clinical Trial Overview of CSL Limited 34
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
LFB S.A. 36
Clinical Trial Overview of LFB S.A. 36
Grifols, S.A. 37
Clinical Trial Overview of Grifols, S.A. 37
Biogen Idec Inc. 38
Clinical Trial Overview of Biogen Idec Inc. 38
Eisai Co., Ltd. 39
Clinical Trial Overview of Eisai Co., Ltd. 39
E. Merck KG 40
Clinical Trial Overview of E. Merck KG 40
Astellas Pharma Inc. 41
Clinical Trial Overview of Astellas Pharma Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
Odense University Hospital 42
Clinical Trial Overview of Odense University Hospital 42
National Center for Research Resources 43
Clinical Trial Overview of National Center for Research Resources 43
Assistance Publique – Hopitaux de Paris 44
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 44
Aarhus University 45
Clinical Trial Overview of Aarhus University 45
Erasmus MC 46
Clinical Trial Overview of Erasmus MC 46
Skane University Hospital 47
Clinical Trial Overview of Skane University Hospital 47
The University of New South Wales 48
Clinical Trial Overview of The University of New South Wales 48
Medical University of Vienna 49
Clinical Trial Overview of Medical University of Vienna 49
Oregon Health & Science University 50
Clinical Trial Overview of Oregon Health & Science University 50
Rigshospitalet 51
Clinical Trial Overview of Rigshospitalet 51
Five Key Clinical Profiles 52
Appendix 85
Abbreviations 85
Definitions 85
Research Methodology 86
Secondary Research 86
About GlobalData 87
Contact Us 87
Disclaimer 87
Source 87


【レポート販売概要】

■ タイトル:多発性神経炎(多発性ニューロパチー)治療のグローバル臨床試験動向(2014年下半期)
■ 英文:Polyneuropathies Global Clinical Trials Review, H2, 2014
■ 発行日:2014年7月28日
■ 調査会社:GlobalData
■ 商品コード:GDHC2263CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。